Biogen, Inc. (BIIB)
183.75
+0.42
(+0.23%)
USD |
NASDAQ |
Apr 01, 16:00
183.75
0.00 (0.00%)
After-Hours: 16:05
Biogen Research and Development Expense (TTM) : 1.498B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 7.281B |
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.71B |
| Pfizer Inc. | 10.25B |
| AbbVie, Inc. | 9.096B |